From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists
- PMID: 3076395
From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists
Abstract
Metoclopramide is a stimulant of upper gut motility and an anti-emetic. The mechanisms by which the drug exerts these actions has been the subject of considerable research, which is briefly reviewed in this article. From the viewpoint of drug discovery, the properties of metoclopramide have directly led to the development of selective gut motility stimulants and 5-HT3 receptor antagonists. These events and the potential clinical use of such compounds are reviewed in detail.
Similar articles
-
General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.Arzneimittelforschung. 1991 Jun;41(6):631-4. Arzneimittelforschung. 1991. PMID: 1930352
-
Gastrointestinal prokinetic activity of serotonergic agents.Proc West Pharmacol Soc. 1992;35:117-21. Proc West Pharmacol Soc. 1992. PMID: 1502210 No abstract available.
-
[Prokinetic drugs].Nord Med. 1992;107(11):274-7. Nord Med. 1992. PMID: 1448341 Review. Swedish.
-
[Value of 5-HT3 receptor antagonists, particularly as anti-emetic drugs].Ann Pharm Fr. 1991;49(6):307-16. Ann Pharm Fr. 1991. PMID: 1842169 Review. French.
-
Gastrointestinal motility stimulating drugs and 5-HT receptors on myenteric neurons.Eur J Pharmacol. 1989 Aug 3;166(3):387-91. doi: 10.1016/0014-2999(89)90350-6. Eur J Pharmacol. 1989. PMID: 2806367
Cited by
-
Validation of a column-switching high-performance liquid chromatographic (HPLC) method for determination of ML-1035 and its five metabolites in plasma.Pharm Res. 1992 Jan;9(1):119-25. doi: 10.1023/a:1018948314823. Pharm Res. 1992. PMID: 1589396
-
Ondansetron. Therapeutic use as an antiemetic.Drugs. 1991 Apr;41(4):574-95. doi: 10.2165/00003495-199141040-00006. Drugs. 1991. PMID: 1711961 Review.
-
Pharmacology and metabolism of renzapride : a novel therapeutic agent for the potential treatment of irritable bowel syndrome.Drugs R D. 2008;9(1):37-63. doi: 10.2165/00126839-200809010-00004. Drugs R D. 2008. PMID: 18095752 Free PMC article.
-
The role of medicinal chemistry in drug research.Pharm Weekbl Sci. 1991 Aug 23;13(4):161-6. doi: 10.1007/BF01957740. Pharm Weekbl Sci. 1991. PMID: 1945742 Review.
-
A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.Front Pharmacol. 2018 Sep 4;9:913. doi: 10.3389/fphar.2018.00913. eCollection 2018. Front Pharmacol. 2018. PMID: 30233361 Free PMC article. Review.